Bioactive peptides either present in foods or released from food proteins during digestion have a wide range of physiological effects, including on gut function. Many of the bioactive peptides characterized to date that influence gut motility, secretion, and absorption are opioid agonists or antagonists. The authors review a body of experimental evidence that demonstrates an effect of peptides from food proteins on endogenous (nondietary) protein flow at the terminal ileum of simple-stomached mammals, including adult humans. At least some dietary peptides (1000-5000 Da) significantly enhance the loss of protein from the small intestine, causing an increased amount of protein to enter the colon. Food-derived peptides appear to either stimulate protein secretion into the gut lumen or inhibit amino acid reabsorption or influence both processes simultaneously. The effect of dietary peptides on small-intestine secretory-protein dynamics is discussed in the context of the major components of gut endogenous protein, sloughed cells, enzymatic secretions, mucin, and bacterial protein.
many amino acid sequences and their physiological functions have been defined. Recently, an in vitro digestion system has been described (1) that allows for the continuous collection and characterization of small and intermediate-size peptides formed during the digestion of foods. The potential physiological importance of peptides arising from casein digestion was inferred from the kinetics of enzymatic proteolysis and the amino acid composition of the peptides. It is also now possible to predict the biological activity of given protein fragments using databases that allow alignment between amino acid sequences and those of known bioactive peptides (30) .
Bioactive peptides released from foods during digestion have a wide range of physiological effects: Evidence (37, 58, 117) that peptides can be released during digestion and absorbed to enter the portal blood intact provides a basis to explain the wide range of both local and systemic activities, although the evidence for meaningful levels of peptide absorption (especially for larger peptides) remains controversial. Some bioactive peptides may have more than one biological activity. The peptide β-casomorphin-7, for example, exhibits opioid, ACE-inhibitory, and immunomodulatory effects (61) .
The very existence of food-derived bioactive peptides may partly explain the often-observed varying physiological effect of apparently similar diets. The isolation, characterization, and description of the physiological effects of food-derived bioactive peptides have been the subject of recent comprehensive reviews (18, 48, 50, 63, 65, 81, 88, 98, 108, 111, 119) .
In this overview we review the experimental evidence for an effect of foodderived peptides on gut function and present a summary of our own findings, based mainly on work with monogastric animal models, for an effect of peptides on gut protein secretion and reabsorption. The latter findings are then discussed in the context of factors known to control the major gut secretions.
Food-Derived Bioactive Peptides and Gut Function
There have been several reports describing a role for food-derived bioactive peptides in regulating gastric emptying rate and decreasing gastrointestinal motility in animals (3, 8, 22, 25, 34, 47, 66, 70, 79, 91, 104, 107, 110) and increasing gut secretory and absorptive capacity (5, 6, 16, 26, 27, 32, 39, 40, 80, 90, 96, 103, 121) Food-Derived Bioactive Peptides S7 and gut tissue growth (4, 7) . An effect on satiety has also been reported (35, 77, 82) . It has been shown (33) that fragments of bovine casein macropeptide (CMP) appear in the intestinal lumen and blood of the rat after oral administration. CMP and CMP-derived peptides influence gastrointestinal function (33) and may (80) influence the release of gastrointestinal hormones such as cholecystokinin, gastrin, and somatostatin, thus increasing gastric and pancreatic secretions and decreasing gastrointestinal motility. CMP has been shown (52) to pass from the stomach to the jejunum in significant amounts in humans after the ingestion of milk products and, moreover, has been detected in human plasma (15) .
Many of the food-derived bioactive peptides characterized to date that have specific effects on gastrointestinal tract function are opioid agonists or antagonists. This has led Teschemacher (108) to proffer the view that the dietary-peptide opioidreceptor ligands may indeed be regarded as essential exogenous supplements to the opioidergic systems of the human.
The human endogenous opioidergic system comprises three main types of opioid receptors (α, β, and κ) and their ligands, endogenous opioids with either alkaloid or, more commonly, peptide structures. The endogenous peptides are released in the body systematically from precursor proteins such as proenkephalin, pro-opiomelanocortin, prodynorphin, and hemoglobin, which may then interact with various opioid receptors. The ligand-receptor complex then elicits opioid effects such as antinociception, respiratory depression, sedation, and a slowing of gastrointestinal motility (118) .
In addition to the endogenous opioids there are numerous exogenous opioidreceptor ligands. The potential effects of exogenous opioid-receptor ligands are exemplified by alkaloid compounds extracted from opium, particularly morphine. In addition to these classical exogenous alkaloid opioids, many exogenous opioid-receptor ligands with peptide structures have been described, such as the α-casein exorphins, the β-casomorphins, the casoxins, the gluten exorphins, the hemorphins, and so on. These exogenous opioid-receptor ligands are food derived, being released during the natural digestion of proteins in the alimentary canal. An excellent description of the search for food-protein-derived opioid-receptor ligands is given by Teschemacher (108) along with an exhaustive summary of the many food-protein-derived peptides identified to date that possess opioid agonist or antagonist activity.
Although many exogenous peptide opioid-receptor ligands have been identified using in vitro and ex vivo preparations, they have not all been shown, by the conduct of carefully controlled human studies, to be released in the gut after oral ingestion and to elicit effects at physiologically normal concentrations. Nor has prevention of the effect of the supposed opioid peptide always been demonstrated empirically by administration of a specific antagonist. Such concrete in vivo evidence is required before the physiological significance of the role of food-protein-derived opioid-receptor ligands can be fully established.
The affinities of natural (not synthesized) food-protein-derived opioid-receptor ligands to opioid receptors are relatively weak (49) . However, the intragastric concentrations of the dietary peptides may be relatively high, and therefore the balance between the opioid agonist and antagonist peptides derived from food is potentially an important component of the overall opioidergic system in humans. In the neonate, in whom milk provides tailored nutrition, the effects of milk-derived peptides as part of the overall opioidergic system might assume an even greater significance.
The β-casomorphins were the first opioid peptides identified from food proteins, and to date they are the most studied of all of the opioid peptides, with β-casomorphin-11 and β-casomorphin-7 having been characterized as digestion products in vivo (62, 64, 99, 106) . In adult humans the effects of the casomorphins appear to be limited to the gastrointestinal tract, because they are either not absorbed or are subject to enzymatic breakdown during absorption (109) . There is evidence, however, that in infants, β-casomorphins may be transported from the blood to the brain stem and the cardiovascular compartment (78, 109) .
There is an interaction between casomorphins and opioid receptors located on the serosal side of the intestinal epithelium, with a subsequent increase in electrolyte transport and a potential effect on antisecretory activity (5, 9) . Casomorphins are known to exert an antidiarrheal action by enhancing water and electrolyte absorption in both the small and the large intestine (22) . The casomorphins are also capable of modulating amino acid transport and have been shown to stimulate the secretion of insulin and somatostatin in dogs, an effect that is inhibited by naloxone (93, 94) . Both oral and intravenous administration of wheat-gluten exorphins in rats have been shown to stimulate (naloxone-antagonizable) postprandial insulin release (36) . Peptides from both β-lactoglobulin and serum albumin (albutensin A) have been reported to induce contraction of smooth muscle (120) . A direct effect of β-casomorphins on gastrointestinal cells has been demonstrated in various in vitro studies (5, 10, 24, 31, 112) . Peptones have been shown to stimulate cholecystokinin secretion and gene transcription in an intestinal cell line (20) and to interact with intestinal endocrine L-cells to increase glucagon-like peptide-1 secretion (21) .
In summary, therefore, a firm basis exists in the literature for the contention that bioactive peptides released from food-protein sequences during digestion in the mammalian alimentary canal influence the functioning of the gastrointestinal tract and the overall digestive process.
Experimental Evidence for an Effect of Dietary Peptides on Overall Gut Protein Secretion and Reabsorption Processes
Studies in our own laboratory of gut digesta protein flows in humans and simplestomached mammals (animal models) provide an opportunity to ascertain the effects of dietary proteins and peptides on endogenous (of body as opposed to dietary origin) amino acid flows at the terminal ileum and are summarized herein. Protein and amino acid flows at the end of the ileum were determined after the provision of semisynthetic-cornstarch-based diets differing in the source of dietary nitrogen (protein free, synthetic amino acids, proteins, hydrolyzed proteins). A range of methods specifically developed to determine endogenous ileal amino acid flow in simple-stomached animals and humans was applied. These methods have been validated and are discussed fully by Moughan et al. (75) . The reader is referred to this review for a detailed description of the approaches. The flow of digesta amino acids of endogenous origin at the terminal ileum is the net result of the secretion of proteinaceous materials into the digestive tract (mouth to terminal ileum) and the continuous reabsorption of amino acids from the digestive lumen. Around 80% of secreted protein is thought to be broken down and reabsorbed during transit through the digestive tract (102) , and such reabsorption is an important component of amino acid supply to the portal vein. Our measure of terminal ileal digesta amino acid flow is, therefore, an indicator of the overall protein dynamics in the upper digestive tract (mouth to terminal ileum) consequent on the ingestion of a meal, and it is reflective of the various physiological and dietary controls on the secretion and reabsorption processes. Tables 1A and 1B provide a summary of studies with simple-stomached mammals and humans. Comparison was made between essentially protein-free diets and diets containing protein or protein hydrolysates. The results span a number of animal species and are from controlled studies in which all dietary components were kept constant except for the component of experimental interest. They provide compelling evidence that the presence of dietary protein or peptides in the lumen of the digestive tract leads to a considerably higher outflow of endogenous digesta amino acids from the ileum into the colon. For example, the ingestion of protein or peptides (vs. protein-free diet) resulted in an 80% increase (average across studies) in endogenous lysine outflow compared with a protein-free diet. The comparable percentage increase for glutamic acid was 220%, and for total nitrogen, 90%. It is therefore inferred that proteins or variously sized oligopeptides either stimulated gut protein secretion into the lumen compared with the protein-free diet, depressed endogenous amino acid reabsorption from the gut lumen, or both.
An obvious possible explanation for these observations is that when no protein is supplied by the diet and the gut is deprived of a luminal source of amino acids (as with a protein-free diet) the secretion of gut proteins is depressed because of a direct lack of luminal amino acid supply. However, this does not appear to be the reason for the lower endogenous losses with the protein-free diet.
In several studies we have given animals the same semisynthetic-cornstarchbased diet, in which the source of dietary nitrogen was synthetic free amino acids. By not including certain dietary nonessential amino acids in some of the diets and by omitting certain dietary essential amino acids in others (with accompanying intravenous amino acid infusion) we could directly measure endogenous amino acid loss from the ileum. In these studies, the animals consumed the amino acidcontaining diets readily, grew normally, and were in positive body nitrogen balance. However, despite the animals' having positive body nitrogen balance and receiving a balanced gut luminal supply of amino acids, the animals had endogenous amino acid flows that were no higher than those of the control (protein-free) animals. In addition, the endogenous amino acid flows were statistically significantly lower than those of animals given peptides (Table 2 ). It is interesting that the endogenous ileal amino acid and total nitrogen flows for the meat-eating cat and dog were markedly higher in general than those of the other simple-stomached species. However, when the pig received a high-protein diet (20% EHC, 1000-5000 Da), more comparable to the protein levels of the cat and dog diets, it also had a higher endogenous ileal total nitrogen loss (see Table 2 , reference 45). A dose-response effect of dietary peptides on gut endogenous amino acid loss has been documented (44, 45) .
In a recent study by our group a highly hydrolyzed casein protein (PeptoPro, <1000 Da) supported a lower ileal endogenous protein flow than intact casein and a flow similar in magnitude to that found when protein-free diets are administered (104) 522 (118) 499 (145) 426 (78) 442 (85) 472 (97) 293 (34) 275 (60) 461 ( (12) 223 (68) 319 (38) Phenylalanine -274 (51) 243 (46) ---168 (14) 237 (12) 278 (17) Tyrosine -298 (61) 239 (74) ---184 (13) 179 (11) 244 (26) Threonine -692 (48) 533 (91) ---612 (36) 525 (69) 909 (59) Leucine -585 (117) 469 (105) ---450 (42) 386 (51) 528 ( (96) 614 (60) 287 ( (73) 857 (28) 434 ( (A. Awati, A.K. Kies, and P.J. Moughan, unpublished). The highly hydrolyzed protein behaved similarly to free amino acids. It appears that extensive hydrolysis removed any effect of bioactive peptides. It seems, therefore, based on the information presented in Tables 1 and 2 , that dietary peptides whether supplied directly (protein hydrolysates) or arising from protein digestion have a direct and major effect on gut protein secretory and reabsorption processes. Such an effect is consistent with the general effects of food-protein-derived opioid-receptor ligands discussed earlier.
The main components of endogenous protein found at the terminal ileum are thought to be desquamated epithelial cells and cellular material, enzymes, mucin, and bacteria (the latter are not strictly endogenous but are measured as part of the endogenous flow). What is the evidence for an effect of diet-derived peptides on these components?
Sloughed Cells
Gastrointestinal epithelial cells are rapidly renewed, leading to a continuous shedding of cells into the gastric and intestinal lumen. Therefore, cells and cellular fragments are an important component of endogenous ileal protein. The migration of a columnar cell from the proliferate crypt zone to the surface in the human small intestine, for example, takes approximately 5-6 d in the duodenum-jejunum and 3 d in the ileum (56) . The rate of cellular proliferation is influenced by a number of hormones and growth factors, including gastrin, somatostatin, epidermal growth factor, growth hormone, estrogen, testosterone, glucocorticoid, secretin, thyroxin, hydrocortisone, and serotonin (56) . A homeostatic balance is achieved between 1 Laboratory rat receiving crystalline AA-based or protein-free diets. Lysine infused intravenously for lysinedeficient diet (100). 2 Laboratory rat receiving crystalline AA-based, protein-free, or EHC-based diet. The digesta were not treated (23) . 3 Twenty-kilogram live-weight growing pigs receiving crystalline AA-based, protein-free, or EHC-based diet. Lysine intravenously infused for lysine-deficient diet. EHC digesta were centrifuged and ultrafiltered (10,000 Da MW cut-off) (13) . NS indicates that the mean flow was not significantly greater than that for the protein-free control. Means with different superscripts within a study and row were significantly different (P < 0.05).
stimulatory and inhibitory activity. In addition, the nervous system has a direct effect on gastrointestinal cell proliferation. Inhibition of cholinergic neural activity induced cell renewal (55, 97) . Stimulation of the α-adrenergic system using norepinephrine and β-blockade by propanolol both stimulate cell renewal, whereas β-adrenergic stimulation with epinephrine or isoproterenol and α-blockade using phentolamine have the opposite effect (56) . Surgical sympathectomy and chemical sympathectomy likewise inhibit cell renewal (115) . Electrical stimulation of the neuromuscular bundle innervating an exteriorized loop of rat jejunum led to increased cellular mitosis (114) , and the vagus may have an atropic affect in the stomach (53, 86) . It is well established (refer to the preceding section) that foodderived peptides can influence hormonal release, and the opioid receptor ligands can also interact with and influence the nervous system. Opioid receptors are found in the antral and peripheral nervous systems, the immune system, and the endocrine system of mammals (108) . There are also some reports in the literature (46, 83, 84) indicating that the administration of dietary peptides to animals influences gut cellular proliferation. Rats given a liquid elemental diet had lowered epithelialcell proliferation rates in the colon (105), although more recently Sales et al. (89) concluded that cellularity and crypt cell mitosis in the rat resected gut were not influenced by the extent of polymerization of the protein source (protein, peptides, free amino acids) when all other components of the diet were controlled and dietary food intake was equalized. Azuma et al. (4) found that tryptic fragments of human β-casein stimulated DNA synthesis in BALB C3T 3 mouse cells, and dietary peptides may improve wound healing in rats (85). Birke et al. (7) have reported a stimulatory effect of food-derived peptides on intestinal tissue growth in the rat.
Enzyme Secretion
Gastric, pancreatic, and intestinal secretions are controlled by hormones (especially cholecystokinin, secretin, and gastrin) and the vagal nervous system. Meal-induced secretion is the net result of stimulation and inhibition elicited by intraluminal and postabsorptive effects of nutrients (17, 116) . Glucagon, somatostatin, and pancreatic polypeptide are thought to be involved in the inhibition of postprandial pancreatic secretion. The important intestinal mechanisms that are influenced by intraluminal products of protein digestion include the release of cholecystokinin into the circulation and the initiation of cholinergic reflexes from gut to pancreas. Little is known, however, about the specific receptor sites and mechanisms. Peptide neurotransmitters in the brain are seemingly important mediators of the cephalic phase of pancreatic secretion. Intracerebroventricular administration of β-endorphin inhibits thyrotropin-releasing hormone and stimulates pancreatic secretion in rats.
It is well known that for humans (though not for rats) partial hydrolysates of protein are potent stimulants of gastric acid and pancreatic secretions, although it is notable that free amino acids are also somewhat stimulatory. Much of the earlier work has been reviewed by Solomon (101) , and the more recent findings of Hira et al. (43) and Matsuno et al. (60) are confirmatory. Stan and Chernikov (103) reported that a peptide released early on during the digestion of casein (κ-caseinoglycopeptide) inhibited acid secretion and gastrin release in the rat stomach. Recently, Calbet and Holst (14) found that when cow-milk hydrolysates (peptides) were given to human subjects, 50% more gastric secretion was observed compared with whole proteins. The enhanced secretion was accompanied by higher plasma levels of glucose-dependent insulinotropic polypeptide during the first 20 min of gastric emptying. Glucagon-like peptide-1 and peptide YY responses were not affected.
Mucin
Gastrointestinal mucus covers the mucosal surfaces of the digestive tract and is a complex mixture of glycoproteins, water, serum, and cellular macromolecules, electrolytes, microorganisms, and sloughed cells. Its properties are largely a result of the gel-forming mucus glycoproteins (mucin) synthesized and secreted by specialized "mucous cells." Mucins are produced and secreted from the mucous cells of salivary glands, esophagus, stomach, and small and large intestines, as well as the gall bladder and pancreatic ducts, and have a protective and lubricating role. Although mucins contain a considerable amount of carbohydrate (>50% by weight) they are also rich in amino acids (especially threonine and serine). Diet has a central role in influencing the production of mucins (67, 76) , and mucin biosynthesis is affected by agents influencing the rate of migration of epithelial cells from the proliferative crypt zone to the villus tip (see earlier section). Cholinergic innervation after stimulation of the vagus or splanchnic nerves, as well as receptors on the basolateral membranes of epithelial cells, appears to be important in the regulation of mucin synthesis (76) , and hormones such as gastrin, cholecystokinin, and secretin are candidate secretagogues. Mucus also contains bacteria and protozoa, which are important for the breakdown of secreted mucus in the digestive tract (cf. build-up of mucus in germ-free animals), and the rate of breakdown may in turn be influenced by diet. Shiau and Chang (95) found that guar gum, pectin, and carrageenan lowered bacterial enzyme activity (mucinases) responsible for mucin degradation, whereas cellulose and fiber-free diets were associated with higher mucinase levels. An effect of dietary protein on gut mucus secretion in pigs has been reported (59) . In pigs fed a diet containing isolated soybean protein, the ileal hexosamine excretion increased when the dietary crude protein content exceeded 55 g/kg dry matter. In calves fed milk substitutes the flow of mucin protein at the duodenum (but not the ileum) increased significantly with increases in dietary crude protein (69) . In a further study with calves (68) the administration of a hydrolyzed soya isolate substantially increased mucin protein loss at the duodenum in comparison with skim-milk powder.
A particularly interesting study was recently reported by Claustre et al. (19) , who investigated the specific effect of dietary peptides on intestinal mucus production, using an isolated vascularly perfused rat jejunum preparation. Luminal administration of a casein hydrolysate at physiological levels stimulated mucin secretion as much as 4-fold. A lactalbumin hydrolysate also stimulated mucin discharge, whereas an egg albumin hydrolysate showed a tendency to increase mucin release, but the result did not reach statistical significance and an enzymatic meat hydrolysate failed to induce a statistically significant increase in mucin production. However, luminal administration of native casein, native egg albumin, an amino acid mixture, glutamine, or glutamic acid did not induce mucin production. The casein hydrolysate-induced mucin secretion was not observed when TTx (a neuronal blocker) was administered intra-arterially, and the casein hydrolysate-induced mucin secretion was also inhibited by naloxone (an opioid antagonist). Luminal administration of the opioid peptide β-casomorphin-7 gave rise to a sharp increase in mucin discharge (563% of control), a response also inhibited by naloxane. β-Casomorphin-7 also induced mucin secretion when administered intra-arterially, and the response was dose dependent. It appears, from this pivotal study (19) and an accompanying study (113) , that intestinal mucin production is greatly affected by the luminal presence of certain dietary peptides. However, not all protein hydrolysates are equally potent in eliciting such an effect. The casein hydrolysate-induced mucin secretion, at least, was triggered by a neuronal pathway and was mediated by opioid-receptor activation. There is clear evidence that β-casomophin-7 specifically induced mucin release in the rat jejunum. Larson et al. (51) have demonstrated that an internal peptide from serum amyloid A 3 can stimulate intestinal MUC3 expression, and recent work from our own group (K-S. Han, W. Miner-Williams, and P.J. Moughan, unpublished data) provides evidence for an effect of peptides from casein up-regulating the expression of MUC3 mRNA in the small intestine of the rat (Figure 1 ). Among the different mucin genes, MUC2 and MUC3 are the predominant ileocolonic mucins. MUC2 mucins are highly expressed in the goblet cells of the small and large colon, and MUC3 mucins are expressed in goblet cells and enterocytes of the small intestine. 
Bacteria
Bacteria are an important component of the gut "endogenous" (though strictly speaking nondietary) protein flow. Little is known about factors regulating their growth in the upper digestive tract, and it is conceivable that the source of dietary nitrogen (protein, peptide, free amino acid) could affect bacterial growth and metabolic activity. The importance of bacterial mucinase production to gut mucin breakdown was discussed previously, and there may be a link between gut bacterial activity, mucin persistency, and, thus, endogenous mucin production. Peptides that stimulate the growth of probiotic bacteria have been detected in a pepsin digest of human milk (57) , and the bifidogenic effects of 2 peptides derived from lactoferrin were found to be 100 times greater than N-acetyl-glycosamine, well known for its prebiotic activity (54) .
There is evidence that food-derived peptides can modulate directly the microbial flora of the gastrointestinal tract. It has been demonstrated that bioactive peptides from food inhibit cariogenic bacteria (2) , and proteolytic fragments of ovalbumin showed strong antimicrobial activity to B. subtilis and, to a lesser extent, other strains. The effect of such peptides on the commensal flora of the intestine, however, has not been clearly demonstrated in vivo.
Conclusions
Peptides released from food proteins during digestion may engage with specific receptor sites in the gastrointestinal tract and influence gut secretory and metabolic processes both positively and negatively. Such effects might be mediated directly or via the hormonal and nervous systems and may help explain the heightened flow of endogenous digesta protein at the end of the ileum of simple-stomached mammals and humans, found in response to protein/peptide versus amino acid alimentation.
The effect of dietary peptides of different sizes and from different proteins on the various major components of endogenous ileal protein flow (desquamated cells, enzymes, mucus, and bacteria) now needs to be ascertained along with potential effects on the rate of reabsorption of endogenous amino acids. Once there is a clearer understanding of the source or sources of the extra protein and their response to dietary peptides, more mechanistic studies into the potential role of bioactive peptides from different protein sources need to be undertaken.
The considerable body of evidence reviewed here for an effect of peptides from food proteins or protein hydrolysates on gut secretory activity has important practical implications for estimating dietary amino acid and protein requirements, for energy metabolism and dietary energy requirements (the gut is a highly metabolic organ), and via the observed effect on mucus secretion for immune-system function. The implications in terms of gut health and human well-being and for sports performance and postexercise recovery remain to be elucidated. Protein hydrolysates differ from each other nutritionally, and they also may not be equal with respect to the physiological effects they elicit. It might be possible to tailor protein hydrolysates (via manipulation of bioactive peptide content) for specific physiological endpoints and practical applications.
